About 3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one
3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one (PubChem CID 127623579) has the molecular formula C14H21N3O2S
and a molecular weight of 295.41 g/mol. Its IUPAC name is 3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one.
Analyze 3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one?
The IUPAC name of 3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one (CID 127623579) is 3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one.
What is the SMILES notation for 3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one?
The canonical SMILES for 3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one is CN1CCC(SCc2noc(C3CCCCC3)n2)C1=O.
What is the InChIKey of 3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one?
The InChIKey is YSLAKIGKXFPFKP-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H21N3O2S/c1-17-8-7-11(14(17)18)20-9-12-15-13(19-16-12)10-5-3-2-4-6-10/h10-11H,2-9H2,1H3.
What are the key properties of 3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one?
3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one has a molecular weight of 295.41 g/mol, XLogP of 2.58, 4 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methylsulfanyl]-1-methylpyrrolidin-2-one is sourced from PubChem (CID 127623579), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).